Featured Research

from universities, journals, and other organizations

Dangerous side effect of common drug combination -- Paxil and Pravachol -- discovered by data mining

Date:
May 29, 2011
Source:
Stanford University Medical Center
Summary:
A widely used combination of two common medications may cause unexpected increases in blood glucose levels, according to a new study. Researchers were surprised at the finding because neither of the two drugs -- one, an antidepressant marketed as Paxil, and the other, a cholesterol-lowering medication called Pravachol -- has a similar effect alone.

A widely used combination of two common medications may cause unexpected increases in blood glucose levels, according to a study conducted at the Stanford University School of Medicine, Vanderbilt University and Harvard Medical School. Researchers were surprised at the finding because neither of the two drugs -- one, an antidepressant marketed as Paxil, and the other, a cholesterol-lowering medication called Pravachol -- has a similar effect alone.

The increase is more pronounced in people who are diabetic, and in whom the control of blood sugar levels is particularly important. It's also apparent in pre-diabetic laboratory mice exposed to both drugs. The researchers speculate that between 500,000 and 1 million people in this country may be taking the two medications simultaneously.

The researchers' study relied on an adverse-event reporting database maintained by the U.S. Food and Drug Administration and on sophisticated electronic medical records used by each of the three participating institutions. They used data-mining techniques to identify patterns of associations in large populations that would not be readily apparent to physicians treating individual patients.

"These kinds of drug interactions are almost certainly occurring all of the time, but, because they are not part of the approval process by the Food and Drug Administration, we can only learn about them after the drugs are on the market," said Russ Altman, MD, PhD, professor of bioengineering, of genetics and of medicine at Stanford.

Although some physicians and researchers have questioned the usefulness of the databases to change medical practice, this study underscores their importance.

"It's very exciting because we were led to this conclusion by mining data that already exists, but of which many people were skeptical," said Altman. "Physicians tend to think of electronic medical records as ways to better track data about single patients, but there's another really important component to them -- their utility in looking at population effects. The information is there to change health-care practice in a meaningful, substantial way."

Altman, the Guidant Professor for Applied Biomedical Engineering and the chair of Stanford's bioengineering department, is the senior author of the study, which will be published online May 25 in Clinical Pharmacology and Therapeutics. The first author of the research, Nick Tatonetti, is a graduate student in biomedical informatics in Altman's laboratory.

It's not uncommon for medications to have effects together that they don't display alone. However, because most drugs are tested and approved independently, it can be difficult or impossible for clinicians to predict the effects of drug combinations. To learn more, the FDA encourages physicians to report any adverse events a patient may have to their Adverse Event Reporting System, or AERS. Such reporting is voluntary, however, and relies on a patient or a physician noticing that something unusual has happened. It also often doesn't include any follow-up to identify the cause of the event or symptom.

Altman and his colleagues used a technique called latent signal detection to identify random pairs of drugs that caused diabetes-related symptoms, such as altered blood sugar levels. To do so, they began by looking in the AERS for individual drugs known to cause side effects reminiscent of diabetes, such as high blood sugar. They then amassed a profile of symptoms related to hyperglycemia, including fever and fatigue, which occur in patients receiving these drugs.

"We were able to create a symptomatic 'fingerprint' to predict glucose-altering drugs," said Altman. "We then looked for that fingerprint in people who were receiving pairs of drugs not known to affect blood sugar levels." The researchers found four pairs of drugs that seemed to cause such symptoms only in combination; they concentrated on Paxil and Pravachol because they are so commonly prescribed.

"Between 13 and 15 million people in this country have prescriptions for these drugs," said Altman. "By extrapolating from the electronic medical records at Stanford and elsewhere, we can predict that between 500,000 and 1 million people are taking them simultaneously."

However, despite the suggestive nature of the symptoms, none of the patients in AERS who were taking the two drugs were directly reported to have hyperglycemia. To demonstrate a direct connection, the researchers turned to electronic medical records at the three participating institutions. They found that 135 non-diabetic people who had prescriptions for both of the drugs experienced an average increase in their random blood glucose levels of 19 mg/dl after beginning treatment. They also found that 104 people with diabetes experienced an even greater average increase: 48 mg/dl after being prescribed both drugs.

The increases are significant because people with two consecutive, fasting blood glucose levels of 126 mg/dl or higher are considered to be diabetic, and people with levels between 100 and 125 mg/dl are considered to have impaired fasting glucose levels and to be pre-diabetic.

"Understanding and mitigating the effect this pair of medications has on blood sugar could allow a person with diabetes to better control his or her glucose levels, or even prevent someone who is pre-diabetic from crossing that threshold into full-blown diabetes," said Altman.

The researchers then looked at the effect of the two medications in laboratory mice fed a high-fat, high-calorie diet. After several weeks on such a diet, the mice typically become insulin resistant and are considered to be pre-diabetic. They found that the pre-diabetic mice experienced an increase in fasting glucose levels after several weeks on the diet. Neither medication alone increased this baseline level. But when they were given Paxil and Pravachol together for three weeks, the glucose levels of the mice increased dramatically -- from about 128 mg/dl to 193 mg/dl.

Altman pointed out that the bioinformatics studies of the databases allowed the mouse experiments to be very focused and targeted. As a result, they were completed more quickly and less expensively than traditional drug screening studies in animals.

The researchers are now applying similar detection methods to identify drug combinations that affect things other than blood glucose levels. The challenge, Altman said, is to triage and prioritize the many intriguing results.

"Post-marketing surveillance of drugs has traditionally been very difficult," said Altman. "The FDA is doing the best it can, but it may be time to embrace some new bioinformatics methods. This study shows that we can identify previously unsuspected issues that may affect hundreds of thousands of people around the world." Stanford is organizing a group of faculty dedicated to using population-based data to make biomedical discoveries.

Other Stanford researchers involved in the work include graduate student Guy Fernald; clinical and translational research informatics specialist Gomathi Krishnan, PhD; cardiovascular medicine instructor Patrick Yue, MD; and associate professor of medicine Philip Tsau, MD.

The research was supported by the National Institutes of Health.


Story Source:

The above story is based on materials provided by Stanford University Medical Center. The original article was written by Krista Conger. Note: Materials may be edited for content and length.


Journal Reference:

  1. N P Tatonetti, J C Denny, S N Murphy, G H Fernald, G Krishnan, V Castro, P Yue, P S Tsau, I Kohane, D M Roden, R B Altman. Detecting Drug Interactions From Adverse-Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose Levels. Clinical Pharmacology & Therapeutics, 2011; DOI: 10.1038/clpt.2011.83

Cite This Page:

Stanford University Medical Center. "Dangerous side effect of common drug combination -- Paxil and Pravachol -- discovered by data mining." ScienceDaily. ScienceDaily, 29 May 2011. <www.sciencedaily.com/releases/2011/05/110525120043.htm>.
Stanford University Medical Center. (2011, May 29). Dangerous side effect of common drug combination -- Paxil and Pravachol -- discovered by data mining. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2011/05/110525120043.htm
Stanford University Medical Center. "Dangerous side effect of common drug combination -- Paxil and Pravachol -- discovered by data mining." ScienceDaily. www.sciencedaily.com/releases/2011/05/110525120043.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins